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Abstract: The efﬁ  cacy of nucleus-targeted drug- or gene-carrying nanoparticles may be limited 
by slow transport through the molecularly crowded cytoplasm following endosome escape. 
Cytoskeletal elements and cellular organelles may pose steric and/or adhesive obstacles to the 
efﬁ  cient intracellular transport of nanoparticles. To potentially reduce adhesive interactions 
of colloids with intracellular components, the surface of model nanoparticles was coated with 
polyethylene glycol (PEG). Subsequently, multiple-particle tracking (MPT) was used to quan-
tify the cytoplasmic transport rates of particles microinjected into the cytoplasm of live cells. 
PEGylation increased average nanoparticle diffusivities by 100% compared to unPEGylated 
particles (time scale of 10 s) in live cells. Faster particle transport correlated with a marked 
decrease in the number of particles that underwent hindered transport, from 79.2% (unmodiﬁ  ed) 
to 48.8% (PEGylated). This result adds to an impressive list of positive beneﬁ  ts associated with 
PEGylation of drug and gene delivery vectors.
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Introduction
Targeted intracellular delivery of drugs and genes to the cell nucleus involves the 
transport of delivery vehicles through the crowded cytoplasm (Lechardeur et al 2005; 
Pack et al 2005). In addition to steric hindrances, adhesive interactions with intracel-
lular components may act to signiﬁ  cantly reduce the cytoplasmic transport rates of 
therapeutic colloids. Nonviral polyethylenimine (PEI)/DNA nanocomplexes are 
actively transported along microtubules to the perinuclear region of cells within 
30 minutes post-transfection (Suh et al 2003). However, vectors that successfully escape 
endosomes in the perinuclear region of cells may still have to traverse distances of up to 
several micrometers through the molecularly crowded cytoplasm prior to reaching nuclear 
pore complexes, the entryway into the nucleus. Therefore, inefﬁ  cient transport of particles 
outside of endosomes may critically limit effective drug and gene therapies.
Surface-modiﬁ  cation of delivery vehicles with polyethylene glycol (PEG), or 
PEGylation, has shown promise as a method to improve the stability and in vivo 
performance of various non-viral drug and gene vectors (Sanders et al 2002; Ogris 
et al 2003; Lenter et al 2004; Mishra et al 2004; Pun et al 2004; Sun et al 2005; Zahr 
et al 2005). In addition, PEGylation has recently been shown to dramatically improve 
particle transport through biological obstacles, such as mucus from healthy volunteers 
(Lai et al 2007) or patients with cystic ﬁ  brosis (Hanes et al 2004). We hypothesized 
that PEGylation of therapeutic colloids may also improve their cytoplasmic transport 
(once the particles have escaped endosomal vesicles) by minimizing attractive forces to 
cytoskeletal elements, such as microtubules or actin ﬁ  laments, or to other intracellular 
organelles. Here, multiple particle tracking (MPT) (Suh et al 2003, 2004, 2005) is used 
to compare the real time transport rates of individual PEGylated and unPEGylated 
polymeric nanoparticles in live cells.International Journal of Nanomedicine 2007:2(4) 736
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Materials and methods
Cell culture
HeLa cells (American Type Culture Collection, Manassas, 
VA) were cultured at 37 °C in 5% CO2 in minimum essential 
medium (MEM, Invitrogen Corp., Carlsbad, CA) supple-
mented with 10% fetal bovine serum (FBS, Invitrogen Corp., 
Carlsbad, CA) and 1% penicillin/streptomycin (Invitrogen 
Corp., Carlsbad, CA). Cells were grown on 35-mm glass-
bottom dishes (MatTek Corp., Ashland, MA).
Covalent PEGylation of nanoparticles
Di-amine polyethylene glycol (PEG) of molecular weight 
3,400 daltons (Nektar Therapeutics, San Carlos, CA) was 
dissolved in 50 mM 2-(N-morpholino)ethanesulfonic acid 
(MES, Sigma, St Louis, MO) buffer at pH 6.0. The use of 
di-amine PEG may result in a free amine group at the end 
of the surface-bound PEG chains. Yellow-green ﬂ  uorescent 
polystyrene nanospheres (Molecular Probes, Eugene, OR) 
were added to the solution to give ﬁ  nal concentrations of 
10 mg PEG/ml and 1% solids/ml. The nanospheres had 
diameters of 100 nm and were carboxyl-modiﬁ  ed. Following 
a 15 min incubation at room temperature, 1-ethyl-3-
(3-dimethylaminopropyl)-carbodiimide (EDAC, Sigma, 
St Louis, MO) was added to the mixture to a concentration 
of 4 mg/ml. The pH of the solution was adjusted to 6.5 with 
dilute NaOH and incubated on an orbital shaker for 2 h at 
room temperature. To quench the reaction, glycine (JT Baker, 
Phillipsburg, NJ) was added to give a ﬁ  nal concentration of 
100 mM. The solution was incubated for 30 min at room 
temperature and subsequently dialyzed extensively against 
Dulbecco’s phosphate-buffered saline (PBS) in a 300,000 
kDa MWCO Float-a-lyzer (Spectrum Laboratories, Rancho 
Dominguez, CA). Unmodiﬁ  ed microspheres were dialyzed 
similarly to remove all traces of sodium azide originally 
added by the manufacturer.
Microinjection of particles
Prior to microinjection, solutions of PEGylated (PS-PEG) and 
unmodiﬁ  ed nanospheres (PS) were diluted to approximately 
1.8 × 107 particles/ml in distilled water, ﬁ  ltered through a 
0.22 μm syringe ﬁ  lter (Millipore, Billerica, MA) and stored at 
4 ºC. Nanospheres were injected using an Eppendorf Femto-
Jet™ (Brinkmann Instruments, Westbury, NY) at a pressure of 
180 hPa for 1.5s. Microinjection needles, Femtotips I (Brink-
mann Instruments, Westbury, NY), were backloaded with 10 
μl of particle solution using microloader pipetters (Brinkmann 
Instruments, Westbury, NY). Cells were microinjected at 
37 °C in tissue culture medium supplemented with 150 mM 
HEPES (Sigma, St Louis, MO). To facilitate the location of 
microinjected cells for microscopy, cells were microinjected 
only in the vicinity of a cross-mark inscribed onto the dish 
with a diamond-tipped glass scribe. After microinjection, 
cells were immediately washed twice with PBS, supplied 
with fresh tissue culture medium, and incubated for 2 h before 
observation under ﬂ  uorescence microscopy.
Endocytosis of particles
HeLa cells were incubated in the presence of approximately 
1.8 × 1010 PS particles in 1 mL of cell culture media for 3 h at 
37 °C. Prior to observation under ﬂ  uorescence microscopy, 
cells were washed twice with PBS and new media added.
Fluorescence microscopy and multiple 
particle tracking
Cells were maintained at 37 °C with an air stream stage 
incubator (Nevtek, Burnsville, VA) and observed with an 
inverted epiﬂ  uorescence microscope, Axiovert (Carl Zeiss 
Inc., Thornwood, NY), equipped with a 100X/1.4 NA oil-
immersion lens. Movies of particle transport in live HeLa 
cells were obtained at 15 frames per second with a Princeton 
Pentamax camera (Roper Scientiﬁ  c, Trenton, NJ). The mov-
ies were analyzed with the Tracking Objects application in 
MetaMorph software (Universal Imaging Corp., Downing-
town, PA) to obtain particle positions over time. This data 
was then used to calculate mean-square displacements (MSD) 
and effective diffusivities (Deff) of individual particles as 
shown previously (Suh et al 2003; Suh et al 2004). Brieﬂ  y, 
MSD and Deff of individual particles in two dimensions are
 MSD  =  Δx2 + Δy2>. (1)
  Deff = MSD/(4τ) (2)
where τ is time scale. Bulk transport properties were then 
obtained by ensemble-averaging individual transport rates. 
More detailed information on particle tracking can be found 
elsewhere (Suh et al 2005).
Results and discussion
Effect of PEGylation on cytoplasmic 
transport rates
In this study, we quantitatively investigated whether the 
cytoplasmic transport of nanoparticles can be improved by 
surface modiﬁ  cation with PEG. The covalent conjugation 
of PEG onto the surface of model drug delivery particles, 
100 nm polystyrene (PS) nanoparticles, doubles their average International Journal of Nanomedicine 2007:2(4) 737
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transport rate in cells (at a time scale of 10s), as measured by 
ensemble-averaged mean-square displacement (Figure 1A) 
and ensemble-averaged diffusivity (Figure 1B). Time scale 
is the amount of time a particle is allowed to move before 
calculating its displacement from an initial position (Suh et 
al 2005), therefore, MSD increases with time (Figure 1A). 
Our group has shown PEGylation also improves particle 
transport rates by more than two orders of magnitude through 
cystic ﬁ  brosis mucus by reducing particle adhesion (Hanes 
et al 2004).
Average particle diffusivity values for both PS and 
PS-PEG decrease over time scale (Figure 1B), suggesting 
both types of nanoparticles experience sub-diffusive (or 
hindered) transport (Saxton 1994, 1996) in the cytoplasm 
of live cells. This is not surprising, since the cell cytoplasm 
is known to be a highly viscoelastic medium crowded with 
cytoskeletal elements, including microtubules and actin 
ﬁ  laments (Tseng et al 2002). Actin networks can form tight 
meshes in certain areas of the cell, with a mean pore diameter 
of 50 nm (Luby-Phelps 1993, 2000).
To further characterize the differences in the intracellular 
transport of PS versus PS-PEG, the motions of individual 
nanoparticles were classiﬁ  ed into three transport modes (Suh 
et al 2005): diffusive, active, and hindered (encompassing 
immobile and sub-diffusive particles).
Classiﬁ  cation of transport modes
Kusumi and coworkers (Kusumi et al 1993) deﬁ  ned a sta-
tionary, or immobile, mode of transport that reﬂ  ects the 
tight adhesion of the transporting species to rigid cellular 
components. The diffusivity of stationary proteins was 
obtained by assuming that the short-range motion of actively 
transporting species (in this case transmembrane proteins) 
is likely due to the small structural ﬂ  uctuations of the cyto-
skeleton to which the proteins are attached. (To be actively 
transported, the proteins need to be closely associated with 
cytoskeletal ﬁ  laments, such as actin, that underlie the plasma 
membrane.) Unfortunately, a similar methodology could not 
be applied to the particles in this study since microtubules 
in the cytoplasm of cells can experience substantial thermal 
ﬂ  uctuation (data not shown). Particles tightly adhered to 
microtubules, therefore, may display diffusivity values on 
the order of particles moving by diffusive or sub-diffusive 
modes. Multi-color confocal particle tracking studies are 
underway to directly visualize the interaction of particles 
with ﬂ  uorescently labeled microtubules in live cells. These 
studies should help directly determine the extent to which 
particles adhere to cytoskeletal structures as well as estimate 
their transport rates. Until then, we have assigned particles 
as immobile if their diffusivities are not above background 
noise in the particle tracking system.
To determine the mode of transport (ie, diffusive, sub-
diffusive, or active) of the mobile nanoparticles, a parameter 
called Relative Change (RC) is calculated for each particle. 
RC is deﬁ  ned as
  RC = Deff, probed τ/Deff, reference τ  (3)
where the reference time scale (τ) is smaller than the probed τ. 
Therefore, RC is a measure of the relative change in diffusivity 
(Deff) of a single particle over time scale. In theory, particles 
moving by simple diffusion are expected to have constant 
diffusivities over time scale (or a RC value of 1). Deff values 
increasing with time scale (RC values greater than 1) indicate 
actively transported particles, and Deff values decreasing with 
time scale (or RC values less than 1) suggest sub-diffusive 
particles (Dawson et al 2003; Suh et al 2003, 2004, 2005).
Due to the random nature of diffusion, however, the RC 
values of a population of purely diffusive particles will have 
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Figure 1 Average cytoplasmic transport rates of PS or PS-PEG nanoparticles microinjected into live HeLa cells. (A) Ensemble MSD or (B) ensemble diffusivity of PS (open 
circles, n = 101) or PS-PEG (closed circles, n = 86) nanoparticles.International Journal of Nanomedicine 2007:2(4) 738
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a certain spread around the value 1. Therefore, a Monte Carlo 
simulation of 10,000 random walks was used to predict this 
distribution of RC values. Similar to other work in the lit-
erature, the Monte Carlo simulated random walks are based 
on a continuum model with a ﬁ  xed step size and unrestricted 
angle of jump (Saxton 1994). The angle θ, between 0 and 2π, 
is generated with uniform probability and the tracer particle 
is moved at each ﬁ  xed time interval Δτ by
 Δ x = L cos(θ);    xτ+Δτ = xτ + Δx (4)
 Δ y = L sin(θ);  yτ+Δτ = yτ + Δy (5)
where x and y are coordinates in 2-dimensional space and 
L is the step size. To match experimental conditions of 20 
s-movies at 15 frames/s, each particle is simulated for 300 
frames and the individual MSD, Deff, and RC v. time scale 
(τ) are calculated. Because RC is a dimensionless quantity, 
the Monte Carlo ﬁ  ndings can be related to experimental 
results without any conversion factor. Hence, the step size 
L was simply set to 1.
From this theoretical RC distribution of purely diffusive 
particles, upper and lower RC bounds are obtained by plac-
ing 95% of the values between the upper and lower bounds. 
Figure 2 shows the upper and lower RC bounds as dotted 
lines for short (Figure 2A) and long (Figure 2B) time scales. 
Under this criterion, 2.5% of the values are above the upper 
RC bound and 2.5% of the values are below the lower RC 
bound.
Next, by calculating the RC values of each microinjected 
particle for the two time regimes (ie, short and long time 
scales), one can obtain the transport mode that describes the 
particle transport properties over the different length scales. 
For example, if the RCshort for a microinjected particle falls 
below the lower RC bound in Figure 2A, the short-range 
motion of the particle is classiﬁ  ed as sub-diffusive. Then, 
if the RClong for the same particle falls within the upper and 
lower RC bounds, the long-range motion of the particle is 
classiﬁ  ed as diffusive. The overall transport mode of the 
particle is then categorized as sub-diffusive over the probed 
time (Table 1). In our application of tracking the motion of 
nanoparticles in cells, we found it useful to categorize the 
overall particle transport mode (based on values of RCshort 
and RClong ) according to Table 1. The overall transport mode 
categorization of a particle is also veriﬁ  ed by visual inspec-
tion of its trajectory (Suh et al 2004).
Effect of PEGylation on particle 
transport modes
Based on the methodology from the previous section, the 
transport of microinjected nanoparticles was ﬁ  rst categorized 
into immobile and mobile populations. Particles were classi-
ﬁ  ed as immobile if their diffusivities were indistinguishable 
from the noise in our experimental setup. The short-range 
and long-range transport of mobile particles was then fur-
ther classiﬁ  ed into three modes: diffusive, sub-diffusive, 
and active. Diffusive particles are undergoing unrestricted 
Brownian motion, sub-diffusive particles display hindered 
motion (possibly due to cytoplasmic obstacles, such as 
cytoskeletal structures), and actively transported particles 
likely experience motor protein-mediated transport along the 
cytoskeleton. Lastly, the immobile and sub-diffusive groups 
were combined into one hindered transport group.
The majority of both PS and PS-PEG nanoparticles experi-
ence hindered transport at short time scales (Figures 3A and 3C), 
suggesting the short-range motion of most particles is obstructed 
by the molecularly crowded microenvironment in the cell cyto-
plasm. A greater fraction of PEGylated nanoparticles, however, 
falls between the upper and lower bounds (Figure 3C), indicating 
a greater population of PEGylated particles exhibit purely diffu-
sive behavior. At longer time scales, the particle transport mode 
0
0.5
1
1.5
2
0 0.5 1 1.5 2
R
C
Time scale (s)
Upper RC 
bound
Lower RC 
bound
Mean RC
0
0.5
1
1.5
2
02468 1 0 1 2
R
C
Time scale (s)
Upper RC 
bound
Lower RC 
bound
Mean RC
A B
Figure 2 Upper and lower bounds for classifying 95% of 10, 000 simulated random walks as purely diffusive. (A) Bounds for classifying the motion at short time scales as 
purely diffusive. RC is deﬁ  ned as Dτ = 1 s / Dτ = 0.2 s. (B) Bounds for classifying the motion at long time scales as purely diffusive. RC is deﬁ  ned as Dτ = 10 s / Dτ = 5 s.International Journal of Nanomedicine 2007:2(4) 739
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for both types of particles is predominantly diffusive (Figures 3B 
and 3D). Such transition from sub-diffusive to diffusive transport 
modes over time scale is possibly a reﬂ  ection of the relaxation of 
the network structure (Mason et al 1997) deﬁ  ning the cytoplasmic 
microenvironment, and has been predicted for particles undergo-
ing sub-diffusion due to the presence of obstacles (Saxton 1994). 
Alternatively, particles may be associating and dissociating from 
nonspeciﬁ  c binding sites in the cytoplasm.
The overall mode of transport of PS and PS-PEG particles 
was then determined based on the transport mode assign-
ments at the short and long time scales (Table 1). Almost 
80% of microinjected PS particles experience hindered trans-
port in the cytoplasm of live cells (Figure 4), underscoring 
the potential difﬁ  culty in particle transport upon endosome 
escape. In contrast, only about 50% of PEGylated particles 
are classiﬁ  ed as hindered. PEGylation of the nanoparticles 
increases the percentage of diffusive particles ~2-fold, from 
around 18% to 38%. It is possible the presence of PEG 
may reduce the adhesion of nanoparticles to cytoplasmic 
components, thereby affecting particle transport. Improved 
cytoplasmic transport of PEGylated particles may be due to 
reduced electrostatic interactions since PEGylation increases 
the particle zeta potential (in 10 mM NaCl) from −41 mV 
(unmodiﬁ  ed PS) to −4 mV. PS nanoparticles are relatively 
hydrophobic in character; therefore, it is also possible that 
the increased hydrophilicity provided by the PEG coating is 
responsible for decreased van der Waals interactions with 
cytoplasmic components (Hanes et al 2003). The PEG coat-
ing may also act as a steric barrier to particle adsorption to 
intracellular components.
Unexpectedly, about 13% of PS-PEG particles are classi-
ﬁ  ed as actively transported compared to 3% for unmodiﬁ  ed 
PS. Based on the statistical criteria set forth in the previous 
section, only about 2.5% of purely diffusive particles should 
be classiﬁ  ed as active in order to be within expected error. 
It is possible that the 13% of PS-PEG particles categorized 
as actively transported were endocytosed during the micro-
injection, resulting in particles within endosomes. Previous 
work has shown polymeric gene vectors within endosomes 
experience active transport (Suh et al 2003). Several factors, 
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Figure 3 Relative change (RC) of particle diffusivities for mobile PS and PS-PEG particles. Values of RC at the (A) short time scale range (0.2–1 s) and (B) long time scale 
range (5–10 s) for PS particles microinjected into live HeLa cells. Values of RC at the (C) short time scale range (0.2–1 s) and (D) long time scale range (5–10 s) for PS-PEG 
particles microinjected into live HeLa cells. Upper and lower RC bounds for purely diffusive transport are indicated by vertical dotted lines. Particles with RC values that fall 
between these lines are classiﬁ  ed as diffusive. Particles with RC values below the lower RC bound are classiﬁ  ed as sub-diffusive, and those with RC values above the upper 
RC bound are classiﬁ  ed as actively transported.
Table 1 Classiﬁ  cation of the overall particle transport mode 
based on the transport modes determined by RCshort and RClong 
values. D = diffusive, S = sub-diffusive, A = active. Immobile and 
sub-diffusive particles are further grouped together as hindered 
particles.
RC
long
D S A 
D D S A 
S S S A  RC
short
A A A A International Journal of Nanomedicine 2007:2(4) 740
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however, make the endocytosis of PS-PEG during microin-
jection highly unlikely. First, carboxylated PS particles (as 
used in this study) are not internalized readily by cells and 
require greater than one-hour incubation in the presence of 
a high particle concentration to observe particle endocyto-
sis (data not shown). The duration of microinjection in our 
studies lasts less than 30 minutes and the cells are washed 
twice and replenished with new media directly after micro-
injection. In addition, attachment of PEG to the surfaces of 
particles has been observed to decrease particle endocytosis 
(Ogris et al 2001).
When PS particles do enter cells via endocytosis 
(Figure 5), around 17% of particles are actively transported 
(Figure 5B), a value similar to that observed for endocytosed 
PEI/DNA nanoparticles (Suh et al 2003). Endocytosed PS 
particles display 4- and 9-fold greater average diffusivities (at 
time scale of 10 s) than PS-PEG and unmodiﬁ  ed PS particles 
microinjected into the cytoplasm, respectively. Thus, even 
with a similar percentage of particles classiﬁ  ed as active (13% 
for microinjected PS-PEG versus 17% for endocytosed PS), 
the intracellular transport rates obtained for the two cases 
vary substantially. It is possible, although unlikely, that 
PS-PEG particles are able to attract cellular components nec-
essary for active transport. Alternatively, actively transport-
ing PS-PEG (although classiﬁ  ed as “active”) may be better 
classiﬁ  ed as undergoing motor protein-independent directed 
transport. Directed particles may display an overall bias in 
the direction of their trajectory; however, this may be due 
to the structure of the environment surrounding the particle, 
rather than the action of motor proteins. Such environments 
may exist in certain areas of the cell where microtubules are 
highly organized (eg, close to the microtubule organizing 
center). This latter hypothesis is further supported by the 
observation that the trajectory of “actively transporting” 
PS-PEG particles often move an order-of-magnitude less than 
actively transporting PS particles that have been endocytosed. 
Therefore, the length scale of the particle trajectory may 
also need to be taken into account when classifying actively 
transporting particles.
In conclusion, PEGylation of polymeric nanoparticles 
improves their cytoplasmic transport rates (outside of endo-
somal vesicles), possibly by reducing non-speciﬁ  c adhesion 
to cytoskeletal elements. This property may be important in 
allowing drug/gene vectors, which have escaped endosomes, 
to efﬁ  ciently reach the nucleus.
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